This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Duke University. Active years: 2015-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2019
Title: Innovations of Qing Ma in the Field of Sirtuin Activation
Introduction
Qing Ma, an accomplished inventor based in Durham, NC, has made significant contributions to the fields of medicine and biochemistry through her innovative research. With a total of three patents to her name, she is especially renowned for her work in therapeutic applications involving annexin A1 peptides and sirtuin activation.
Latest Patents
Among her latest inventions, Ma has developed a method of treating, ameliorating, or inhibiting sirtuin-associated disorders using annexin A1 peptides. This innovative approach provides a breakthrough in the treatment of various disorders, offering new hope to patients in need. Another notable patent addresses cardiac surgery-associated acute kidney injury (AKI). Here, Ma presents a method of preventing and ameliorating AKI in subjects by administering a therapeutically effective amount of annexin A1 peptide, showcasing the potential of her research in enhancing post-surgical outcomes.
Career Highlights
Qing Ma currently works at Duke University, where she engages in groundbreaking research. Her work focuses on the intersection of biochemistry and clinical applications, leveraging her expertise to address critical medical challenges. Ma's dedication and innovative spirit have earned her recognition in both academic and clinical settings.
Collaborations
Throughout her career, Ma has collaborated with notable colleagues, including Zhiquan Zhang and Mihai V Podgoreanu. These partnerships have fostered a rich environment for scientific inquiry, allowing for the exchange of ideas and the pursuit of cutting-edge research.
Conclusion
Qing Ma stands out as a vital figure in the advancement of medical science through her innovative patents. Her work with annexin A1 peptides not only opens new avenues for treatment but also underscores the importance of collaboration in the pursuit of scientific progress. As she continues her research at Duke University, the medical community looks forward to her future contributions that may positively impact many lives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
